-
1
-
-
79960797525
-
Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis
-
F. Saliba, S. Dharancy, and J. Dumortier et al. Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis Liver Transplant 17 2011 905 913
-
(2011)
Liver Transplant
, vol.17
, pp. 905-913
-
-
Saliba, F.1
Dharancy, S.2
Dumortier, J.3
-
2
-
-
84863226512
-
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT
-
L. Fischer, J. Klempnauer, and H.J. Schlitt et al. A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT Am J Transplant 12 2012 1855 1865
-
(2012)
Am J Transplant
, vol.12
, pp. 1855-1865
-
-
Fischer, L.1
Klempnauer, J.2
Schlitt, H.J.3
-
3
-
-
79952361568
-
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial
-
K. Budde, T. Becker, and U. Eisenberger et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial Lancet 377 2011 837 847
-
(2011)
Lancet
, vol.377
, pp. 837-847
-
-
Budde, K.1
Becker, T.2
Eisenberger, U.3
-
4
-
-
77957583305
-
Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
-
J. Dantal, F. Berthoux, and R. Genin et al. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial Transpl Int 23 2010 1084 1093
-
(2010)
Transpl Int
, vol.23
, pp. 1084-1093
-
-
Dantal, J.1
Berthoux, F.2
Genin, R.3
-
5
-
-
77952945224
-
Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients
-
H. Tedesco Silva Jr., D. Cibrik, and C. Panis et al. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients Am J Transplant 10 2010 1401 1413
-
(2010)
Am J Transplant
, vol.10
, pp. 1401-1413
-
-
Tedesco Silva, Jr.H.1
Cibrik, D.2
Panis, C.3
-
6
-
-
68949212927
-
Indications and management of everolimus after liver transplantation
-
I. Bilbao, G. Sapisochin, and R. Charco et al. Indications and management of everolimus after liver transplantation Transplant Proc 41 6 2009 2172 2176
-
(2009)
Transplant Proc
, vol.41
, Issue.6
, pp. 2172-2176
-
-
Bilbao, I.1
Sapisochin, G.2
Charco, R.3
-
7
-
-
0038782051
-
Rapamycin: Friend, foe, or misunderstood?
-
J. Fung, and A. Marcos Rapamycin: friend, foe, or misunderstood? Liver Transpl 9 2003 469 472
-
(2003)
Liver Transpl
, vol.9
, pp. 469-472
-
-
Fung, J.1
Marcos, A.2
-
8
-
-
33751009117
-
Everolimus and mTOR inhibitors in liver transplantation: Opening the "box"
-
G.T. Everson Everolimus and mTOR inhibitors in liver transplantation: opening the "box" Liver Transplant 12 2006 1571
-
(2006)
Liver Transplant
, vol.12
, pp. 1571
-
-
Everson, G.T.1
-
9
-
-
43849095466
-
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
-
M.A. Zimmerman, J.F. Trotter, and I. Kam et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma Liver Transplant 14 2008 633 638
-
(2008)
Liver Transplant
, vol.14
, pp. 633-638
-
-
Zimmerman, M.A.1
Trotter, J.F.2
Kam, I.3
-
10
-
-
85172998912
-
Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function
-
M. Masetti, R. Montalti, and G. Gerunda et al. Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function Am J Transplant 10 2010 252 262
-
(2010)
Am J Transplant
, vol.10
, pp. 252-262
-
-
Masetti, M.1
Montalti, R.2
Gerunda, G.3
-
11
-
-
59249098555
-
Conversion to everolimus monotherapy in maintenance liver transplantation: Feasibility, safety, and impact on renal function
-
P. De Simone, P. Carrai, and A. Precisi et al. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function Transpl Int 22 2009 279 286
-
(2009)
Transpl Int
, vol.22
, pp. 279-286
-
-
De Simone, P.1
Carrai, P.2
Precisi, A.3
-
12
-
-
37549021099
-
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
-
C.J. Watson, A.E. Gimson, and G.J. Alexander et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function Liver Transpl 13 2007 1694 1702
-
(2007)
Liver Transpl
, vol.13
, pp. 1694-1702
-
-
Watson, C.J.1
Gimson, A.E.2
Alexander, G.J.3
-
13
-
-
84868208723
-
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial
-
P. De Simone, F. Nevens, and G. Junge et al. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial Am J Transplantation 12 11 2012 3008 3020
-
(2012)
Am J Transplantation
, vol.12
, Issue.11
, pp. 3008-3020
-
-
De Simone, P.1
Nevens, F.2
Junge, G.3
|